Mark J. Rieder

32.4k citations
117 papers · 13.0k · 5 hit papers · h-index 54

Impact in

  • Pharmacology top 0.05%
    • Pharmacogenetics and Drug Metabolism
  • Genetics top 0.1%
    • Genetic Associations and Epidemiology
    • Genomics and Rare Diseases
    • Genetic Mapping and Diversity in Plants and Animals
    • Genomic variations and chromosomal abnormalities
    • Genetics and Neurodevelopmental Disorders

Papers in

    • Genetic Associations and Epidemiology 23
    • Genomic variations and chromosomal abnormalities 8
    • Genomics and Rare Diseases 8
    • Genetic Mapping and Diversity in Plants and Animals 6

Mark J. Rieder

117 papers receiving 12.7k citations

Mark J. Rieder's Hit Papers

Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing Studies 2012 · 610 citations
6100+7+14Years since publication4008001.2k

Peers

Mark J. Rieder
Comparison fields: 5 of 175
  • Pharmacology 1.8k
  • Genetics 4.5k
  • Biochemistry 450
  • Cardiology and Cardiovascular Medicine 1.2k
  • Endocrinology, Diabetes and Metabolism 906
Replace Michiaki Kubo with:
Michiaki Kubo Japan
Panos Deloukas United Kingdom
Jerzy Adamski Germany
Beverly Paigen United States
William E. Rainey United States
Paul C. MacDonald United States
Susumu Itoh Japan
Stephen T. Turner United States
Sanjay K. Nigám United States
Jeffrey Baron United States
Mark J. Rieder relative to Michiaki Kubo Japan Michiaki Kubo's profile →
Citations per field
00.5×3.1×
Michiaki Kubo · 1×
Citations per year

Countries citing papers authored by Mark J. Rieder

Since Specialization
Citations

This map shows the geographic impact of Mark J. Rieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Rieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Rieder more than expected).

Fields of papers citing papers by Mark J. Rieder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Rieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Rieder. The network helps show where Mark J. Rieder may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Rieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Rieder Line = papers co-authored together Mark J. Rieder links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selecting a Maximally Informative Set of Single-Nucleotide Polymorphisms for Association Analyses Using Linkage Disequilibrium
Hit paper breakdown →
20041223
2
Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Hit paper breakdown →
2005992
3
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations
Hit paper breakdown →
2011810
4
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
Hit paper breakdown →
2012623
5
Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing Studies
Hit paper breakdown →
2012610
6 1998446
7 2004393
8 1999380
9 2013365
10 2008333
11 2017293
12 2005269
13 2011263
14 2003258
15 2009241
16 2005215
17 2004215
18 2011201
19 2011192
20 2010180

About Mark J. Rieder

Mark J. Rieder is a scholar working on Genetics, Molecular Biology, Pharmacology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 117 papers that have together received 13.0k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (23 papers), Pharmacogenetics and Drug Metabolism (17 papers), Hormonal Regulation and Hypertension (10 papers), Genomic variations and chromosomal abnormalities (8 papers), Genomics and Rare Diseases (8 papers), Renin-Angiotensin System Studies (8 papers), Genetic Mapping and Diversity in Plants and Animals (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Pharmacology (1.8k citations), Genetics (4.5k citations), Biochemistry (450 citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Endocrinology, Diabetes and Metabolism (906 citations). Mark J. Rieder has collaborated with scholars based in United States, South Africa and Germany. Frequent co-authors include Deborah A. Nickerson, Christopher S. Carlson, Michael A. Eberle, Leonid Kruglyak, Allan E. Rettie, Yi Qian, David L. Veenstra, Alex P. Reiner, Michael J. Bamshad and Jay Shendure. Their work appears in journals such as The American Journal of Human Genetics, Nature Genetics, PLoS Genetics, Arteriosclerosis Thrombosis and Vascular Biology and Pharmacogenetics and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact